Bubs Australia’s FY20 Results Out, Revenue Rose by 32%

Australian premium infant formula producer, Bubs Australia Limited (ASX:BUB) disclosed its annual report for FY20 (year ended 30 June 2020), highlights are-

  • During the period, group gross revenue of BUB rose by 32% to A$62 million.
  • Sales of Bubs® Infant Formula in FY20 increased 58% to A$30 million, representing ~55% group revenue.
  • The Company has a robust balance sheet with approximately A$26 million in cash reserves.
  • Bubs’ export markets outside China delivered 5-fold growth, indicating 10% group revenue.

The results during FY20 were driven by the robust performance of Bubs® Infant Formula in each retail regions and channels.





Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK